Dr. Mou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Hawkins Dr
Iowa City, IA 52242Phone+1 319-356-1206
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology and Medical Oncology, 2017 - 2020- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2014 - 2017
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2014
Certifications & Licensure
IA State Medical License 2020 - 2026
CA State Medical License 2015 - 2021
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsThe A-HIPI prediction model in advanced-stage Hodgkin lymphoma: identification of risk groups and creation of an online tool.Matthew J Maurer, Susan K Parsons, Jenica N Upshaw, Angie Mae Rodday, Raphael Mwangi
Blood Advances. 2025-03-25 - 1 citationsOvercoming Tagraxofusp-Erzs Monotherapy Resistance in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in a Real-World Clinical Setting.Prajwal Dhakal, Mario Sy, Grerk Sutamtewagul, Eric Mou, Nanmeng Yu
Journal of Immunotherapy and Precision Oncology. 2024-08-01 - Chimeric antigen receptor T-cell therapy for refractory post-transplant lymphoproliferative disorder after lung transplantation.Kaleb Veit, Tahuanty Peña, Julia Klesney-Tait, Eric Mou, Umar Farooq
JHLT Open. 2024-08-01
Abstracts/Posters
- Brief Pembrolizumab(PEM) Monotherapy Results in Complete and Near Complete Responses in the Majority of Untreated Patients with Classical Hodgkin Lymphoma (cHL): A Mul...Eric Mou, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Fitness and Anthracycline Use in Front-Line Therapy for Older Patients with Classical Hodgkin Lymphoma: A US Multi-Center Retrospective AnalysisEric Mou, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
